BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 225 filers reported holding BRIDGEBIO PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,263,883 | -7.5% | 313,382 | -39.6% | 0.05% | -2.0% |
Q2 2023 | $8,931,031 | +57.8% | 519,246 | +52.1% | 0.05% | +31.6% |
Q1 2023 | $5,658,422 | +3.2% | 341,280 | -52.6% | 0.04% | -17.4% |
Q4 2022 | $5,480,830 | -6.7% | 719,269 | +21.8% | 0.05% | -25.8% |
Q3 2022 | $5,872,000 | +42.7% | 590,740 | +30.4% | 0.06% | +63.2% |
Q2 2022 | $4,114,000 | -35.0% | 453,080 | -27.3% | 0.04% | +2.7% |
Q1 2022 | $6,326,000 | +160.3% | 623,202 | +327.7% | 0.04% | +184.6% |
Q4 2021 | $2,430,000 | -16.2% | 145,704 | +135.5% | 0.01% | -35.0% |
Q3 2021 | $2,900,000 | +16.6% | 61,881 | +51.7% | 0.02% | +25.0% |
Q2 2021 | $2,487,000 | -14.0% | 40,803 | -13.1% | 0.02% | -20.0% |
Q1 2021 | $2,892,000 | +167.5% | 46,950 | +209.0% | 0.02% | +81.8% |
Q4 2020 | $1,081,000 | -34.9% | 15,196 | -65.7% | 0.01% | -45.0% |
Q3 2020 | $1,660,000 | +52.9% | 44,255 | +32.9% | 0.02% | +33.3% |
Q2 2020 | $1,086,000 | +60.9% | 33,309 | +73.1% | 0.02% | +50.0% |
Q4 2019 | $675,000 | – | 19,248 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 6,068,125 | $160,016,456 | 65.94% |
Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $819,077,805 | 28.79% |
Cormorant Asset Management, LP | 4,662,530 | $122,950,916 | 7.17% |
Frazier Life Sciences Management, L.P. | 2,725,949 | $71,883,275 | 4.77% |
Octagon Capital Advisors LP | 971,639 | $25,622,120 | 3.94% |
M28 Capital Management LP | 121,200 | $3,196,044 | 3.66% |
VIKING GLOBAL INVESTORS LP | 25,120,991 | $662,440,533 | 2.69% |
BOONE CAPITAL MANAGEMENT LLC | 313,381 | $8,263,857 | 2.61% |
Fernwood Investment Management, LLC | 235,620 | $6,213,299 | 2.23% |
SOUTHPORT MANAGEMENT, L.L.C. | 15,000 | $395,550 | 2.15% |